Sintx Technologies, Inc. (SINT)
NASDAQ: SINT · IEX Real-Time Price · USD
0.0418
+0.0018 (4.50%)
At close: Apr 19, 2024, 4:00 PM
0.0402
-0.0016 (-3.83%)
After-hours: Apr 19, 2024, 7:59 PM EDT
Sintx Technologies Market Cap
Sintx Technologies has a market cap or net worth of $5.13 million as of April 19, 2024. Its market cap has decreased by -21.11% in one year.
Market Cap
5.13M
Enterprise Value
6.03M
1-Year Change
-21.11%
Ranking
Category
Stock Price
$0.04
Market Cap Chart
Since February 13, 2014, Sintx Technologies's market cap has decreased from $64.00M to $5.13M, a decrease of -91.99%. That is a compound annual growth rate of -21.95%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 19, 2024 | 1.00M | 11.11% |
Apr 18, 2024 | 900.00K | 12.50% |
Apr 17, 2024 | 800.00K | 60.00% |
Apr 16, 2024 | 500.00K | - |
Apr 15, 2024 | 500.00K | - |
Apr 12, 2024 | 500.00K | -16.67% |
Apr 11, 2024 | 600.00K | - |
Apr 10, 2024 | 600.00K | - |
Apr 9, 2024 | 600.00K | - |
Apr 8, 2024 | 600.00K | - |
Apr 5, 2024 | 600.00K | - |
Apr 4, 2024 | 600.00K | 20.00% |
Apr 3, 2024 | 500.00K | -44.44% |
Apr 2, 2024 | 900.00K | - |
Apr 1, 2024 | 900.00K | -18.18% |
Mar 28, 2024 | 1.10M | -8.33% |
Mar 27, 2024 | 1.20M | 500.00% |
Mar 26, 2024 | 200.00K | - |
Mar 25, 2024 | 200.00K | -50.00% |
Mar 22, 2024 | 400.00K | -33.33% |
Mar 21, 2024 | 600.00K | - |
Mar 20, 2024 | 600.00K | - |
Mar 19, 2024 | 600.00K | 20.00% |
Mar 18, 2024 | 500.00K | - |
Mar 15, 2024 | 500.00K | - |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Processa Pharmaceuticals | 4.74M |
Lipella Pharmaceuticals | 4.68M |
Evoke Pharma | 4.65M |
Aditxt | 4.61M |
Helius Medical Technologies | 4.60M |
Seelos Therapeutics | 4.54M |
ZyVersa Therapeutics | 4.42M |
Portage Biotech | 4.40M |